Hit a Colon Cancer Screening Home Run with Cologuard
If you’re 45 or older, it’s time to step up to the plate and get screened for colon cancer. That’s the message in Abbott’s new baseball-themed bilingual ad campaign for the Cologua...
Search fresh public links, source activity, and ready-to-use post angles for Cologuard.
Fresh curated links around Cologuard are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
If you’re 45 or older, it’s time to step up to the plate and get screened for colon cancer. That’s the message in Abbott’s new baseball-themed bilingual ad campaign for the Cologua...
NASHVILLE, Tenn. — An updated version of the blood-based SimpleScreen CRC screening test improved detection of advanced precancerous lesions while maintaining high sensitivity for...
Researchers have developed a blood-based assay that could help identify individuals with precursor lesions for colorectal cancer, a known limitation of many blood-based screening t...
NASHVILLE, Tenn. — A mailed fecal immunochemical test-based outreach program increased colorectal cancer screening rates by more than 50% among underserved adults in New York City,...
Clinicians have more colorectal cancer screening options than ever before. The challenge is helping more eligible patients complete them.Colorectal cancer screening has the power t...
The company behind the colorectal cancer blood test Colvera has hit biotechnology company Grail Inc. with a lawsuit in Delaware federal court claiming the latter's Galleri test inf...
Fair warning: this does NOT replace your colonoscopy (yet).
Fair warning: this does NOT replace your colonoscopy (yet).
NASHVILLE, Tenn — Fecal immunochemical tests appear more sensitive to colorectal cancer and advanced precancerous lesions in men than women, according to a retrospective study pres...
Clinician counseling may be inadequate for younger adults newly eligible for colorectal cancer screening, according to study findings presented at this year’s AACR Conference on Th...
An FDA advisory panel expressed support for a blood test designed to detect early signs of multiple cancers, including some for which no screening alternative exists.Members of the...
Patients across the U.S. will soon have access to a new cervical cancer test collected from the comfort of their own home—no stirrups, speculum, or in-person doctor’s visit needed....
NASHVILLE, Tenn. — A novel DNA methylation test using the EndoSign capsule-sponge detected Barrett’s esophagus with 90% sensitivity and 86% specificity, excelling in longer segment...
Routine blood tests may hold clues about a person’s likelihood of developing colorectal cancer before the age of 45.
Background: Colorectal polyps are a major source of precancerous lesions in colorectal cancer (CRC). In many population-based screening programs, a major challenge is the efficient...
In a new campaign for Guardant’s Shield™, the first FDA-approved blood test for primary colorectal cancer screening, Dempsey urges people to get tested.
Panel members said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings, however.
NASHVILLE, Tenn. — Two machine learning models demonstrated high accuracy in identifying adenomas and sessile serrated lesions, although more research is needed to determine their...
FDA advisory panel voted in favor of GRAIL's Galleri multi-cancer early detection test for adults 50 and older, supporting its safety and benefit-risk profile
I don’t like to preach in these columns. I’d rather poke fun and spoof craven politicians. This world contains many people who believe many different things, and I like to acknowle...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.